Zydus Lifesciences informs about press release

14 Mar 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 14, 2022 titled ‘Zydus receives final approval from USFDA for Colestipol Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.25 -14.50 (-1.61%)
19-Mar-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1767.60
Dr. Reddys Lab 1274.60
Cipla 1258.00
Zydus Lifesciences 884.25
Lupin 2284.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×